| ER stress and distinct outputs of the IRE1α RNase control proliferation and senescence in response to oncogenic Ras N Blazanin, J Son, AB Craig-Lucas, CL John, KJ Breech, MA Podolsky, ... Proceedings of the National Academy of Sciences 114 (37), 9900-9905, 2017 | 79 | 2017 |
| PPARβ/δ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signaling B Zhu, CH Ferry, N Blazanin, MT Bility, C Khozoie, BH Kang, AB Glick, ... Oncogene 33 (46), 5348-5359, 2014 | 55 | 2014 |
| Ligand activation of peroxisome proliferator-activated receptor β/δ (PPARβ/δ) inhibits chemically induced skin tumorigenesis MT Bility, MK Devlin-Durante, N Blazanin, AB Glick, JM Ward, BH Kang, ... Carcinogenesis 29 (12), 2406-2414, 2008 | 53 | 2008 |
| The nuclear receptor peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) promotes oncogene-induced cellular senescence through repression of endoplasmic reticulum stress B Zhu, CH Ferry, LK Markell, N Blazanin, AB Glick, FJ Gonzalez, ... Journal of Biological Chemistry 289 (29), 20102-20119, 2014 | 50 | 2014 |
| Tumor suppressor and oncogene actions of TGFβ1 occur early in skin carcinogenesis and are mediated by Smad3 DS Bae, N Blazanin, M Licata, J Lee, AB Glick Molecular Carcinogenesis: Published in cooperation with the University of …, 2009 | 31 | 2009 |
| TGFβ1-induced inflammation in premalignant epidermal squamous lesions requires IL-17 J Mohammed, A Ryscavage, R Perez-Lorenzo, AJ Gunderson, ... Journal of investigative dermatology 130 (9), 2295-2303, 2010 | 28 | 2010 |
| The multiple roles of the unfolded protein response regulator IRE1α in cancer F Chalmers, S Mogre, J Son, N Blazanin, AB Glick Molecular carcinogenesis 58 (9), 1623-1630, 2019 | 20 | 2019 |
| Peroxisome proliferator-activated receptor β/δ cross talks with E2F and attenuates mitosis in HRAS-expressing cells B Zhu, C Khozoie, MT Bility, CH Ferry, N Blazanin, AB Glick, FJ Gonzalez, ... Molecular and cellular biology 32 (11), 2065-2082, 2012 | 20 | 2012 |
| Activation of a protumorigenic IFNγ/STAT1/IRF‐1 signaling pathway in keratinocytes following exposure to solar ultraviolet light N Blazanin, T Cheng, S Carbajal, J DiGiovanni Molecular Carcinogenesis 58 (9), 1656-1669, 2019 | 18 | 2019 |
| Selective Ah receptor ligands mediate enhanced SREBP1 proteolysis to restrict lipogenesis in sebocytes GE Muku, N Blazanin, F Dong, PB Smith, D Thiboutot, K Gowda, S Amin, ... Toxicological Sciences 171 (1), 146-158, 2019 | 17 | 2019 |
| Twist1 is required for the development of UVB‐induced squamous cell carcinoma F Eguiarte‐Solomon, N Blazanin, O Rho, S Carbajal, DW Felsher, ... Molecular Carcinogenesis 60 (5), 342-353, 2021 | 9 | 2021 |
| Pharmacologic Inhibition of ALK5 Causes Selective Induction of Terminal Differentiation in Mouse Keratinocytes Expressing Oncogenic HRAS LM Markell, KE Masiuk, N Blazanin, AB Glick Molecular Cancer Research 9 (6), 746-756, 2011 | 8 | 2011 |
| The nuclear receptor peroxisome proliferator-activated receptor-b/d (PPARb/d) promotes oncogene-induced cellular senescence through repression of endoplasmic reticulum stress B Zhu, CH Ferry, LK Markell, N Blazanin, AB Glick, FJ Gonzalez, ... J Biol Chem 289, 20102-20119, 2014 | 6 | 2014 |
| The nuclear receptor PPARbeta/delta promotes oncogene-induced cellular senescence through repression of endoplasmic reticulum stress B Zhu, CH Ferry, LK Markell, N Blazanin, AB Glick, FJ Gonzalez, ... J Biol Chem 9 (29), 20102-19, 2014 | 3 | 2014 |
| Angiogenesis and disrupted epidermal structure in mice coexpressing TGF beta 1 and oncogenic ras D Bae, N Blazanin, AB Glick JOURNAL OF INVESTIGATIVE DERMATOLOGY 126, 21-21, 2006 | 1 | 2006 |
| Therapeutic modulation of rock overcomes metabolic adaption to oxphos inhibition and suppresses tumor growth N Blazanin, X Liang, I Mahmud, E Kim, L Tan, NE Anvar, W Chan, MJ Ha, ... Cancer Research 84 (6_Supplement), 5972-5972, 2024 | | 2024 |
| Modulation of enhancer accessibility by SMARCA2 PROTACs synergize with TEAD inhibitors to suppress growth of SMARCA4 mutant lung cancers S Kotagiri, N Blazanin, M Qudrattulah, Y Xi, J Wang, Y Lissanu Cancer Research 84 (6_Supplement), 3304-3304, 2024 | | 2024 |
| Novel SMARCA2 degrading bifunctional molecules as therapeutics in SMARCA4 mutant lung cancer S Kotagiri, N Blazanin, Y Xi, J Wang, Y Lissanu Cancer Research 83 (7_Supplement), 1138-1138, 2023 | | 2023 |
| Enhancer reprogramming by novel SMARCA2 degrading PROTACs underlies therapeutic utility in SMARCA4 mutant tumors S Kotagiri, N Blazanin, Y Xi, J Wang, Y Lissanu Cancer Research 83 (7_Supplement), 6289-6289, 2023 | | 2023 |
| TGFβ1 regulates HRas‐mediated activation of IRE1α through the PERK‐RPAP2 axis in keratinocytes S Mogre, N Blazanin, H Walsh, J Ibinson, C Minnich, CC Andrew Hu, ... Molecular carcinogenesis 61 (10), 958-971, 2022 | | 2022 |
